Syngenta Secures Exclusive Rights to Biofungicide for Asian Rice Markets
Event summary
- Syngenta and Ascribe Bioscience signed a development and supply agreement for PHYTALIX®, a biofungicide effective against fungal, bacterial, and viral diseases in rice and other major crops.
- Syngenta gains exclusive commercial rights to PHYTALIX® for rice and other crops in Southeast Asia, with potential expansion to other regions.
- The product, developed from research at Cornell University, mimics natural plant processes to enhance crop resistance and yield.
- First commercial launches in Asia are planned for 2029 following registration and market development activities.
- PHYTALIX® demonstrated strong results in four years of Syngenta-led trials, supporting integrated pest management (IPM) practices.
The big picture
Syngenta’s partnership with Ascribe Bioscience underscores the growing emphasis on biological solutions in agriculture, particularly in regions like Southeast Asia where rice is a dietary staple. The deal reflects a broader industry shift toward integrating biocontrols with conventional farming practices to address climate-related challenges and pathogen resistance. With rice demand rising and traditional solutions facing limitations, Syngenta’s move positions it as a leader in sustainable crop protection innovation.
What we're watching
- Market Adoption
- The pace at which PHYTALIX® gains acceptance among Asian rice farmers, particularly in the face of climate stress and emerging diseases.
- Regulatory Approval
- Whether Syngenta can navigate registration processes efficiently to meet the 2029 launch timeline across key Asian markets.
- Competitive Response
- How traditional chemical fungicide providers react to Syngenta’s push into sustainable biofungicide solutions.
Related topics